All these results indicate that AMPK, by downregulating PGC‐1α and PPARγ and by upregulating HIF‐1α, could induce HCC stem cell reprogramming and restore sorafenib sensitivity. This evidence concerns the gene HIF1A and hepatocellular carcinoma.